Improving API Solubility: Salt and Cocrystals

WEBINAR

Development of new active pharmaceutical ingredients (APIs) is lengthy and cost-intensive, thus avoiding any potential risk that may limit the product’s success is of utmost importance. Today, many APIs are not being commercialized as they are poorly water soluble (BCS class II and IV) and, as a result, exhibit too low bioavailability. Diverse API processing techniques have evolved to be chosen to improve drug solubility, but also stability and processability. Learn in which cases salt or cocrystal formation are your techniques of choice, how to find the right coformers for your API, and how to avoid the obstacles – so that you can care about commercialization, not solubilization.

In this webinar, you will learn:

• How salt and cocrystal formation can improve your API's solubility
• What are the respective benefits for your API
• How to identify and select suitable coformers for your API
• Which regulatory implications are involved